Sun Pharma gets USFDA nod for drug to treat neonatal seizures

"With this approval, SEZABY becomes the first and only product specifically indicated in the US for the treatment of neonatal seizures in term and pre-term infants," the company said. The drug is expected to be available in the US in the fourth quarter of FY23, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Z4LlwfU
via IFTTT